Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Fate Therapeutics, Inc. (FATE)

2.4500 +0.0200 (+0.82%)
At close: September 2 at 4:00:01 PM EDT
2.4100 -0.0400 (-1.63%)
Pre-Market: 4:21:07 AM EDT
Trade FATE on Coinbase
Chart Range Bar
Loading chart for FATE
  • Previous Close 2.4300
  • Open 2.4300
  • Bid 1.9100 x 200
  • Ask 3.2800 x 200
  • Day's Range 2.3800 - 2.5050
  • 52 Week Range 0.9300 - 3.2300
  • Volume 1,217,068
  • Avg. Volume 3,044,555
  • Market Cap (intraday) 293.56M
  • Beta (5Y Monthly) 2.55
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0500
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.74

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

www.fatetherapeutics.com

161

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

FATE
150.00%
S&P 500 (^GSPC)
11.99%

1-Year Return

FATE
137.86%
S&P 500 (^GSPC)
19.50%

3-Year Return

FATE
12.81%
S&P 500 (^GSPC)
69.77%

5-Year Return

FATE
96.75%
S&P 500 (^GSPC)
68.98%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 1.3M
Earnings -31.21M
Profit Margin -2,402.85%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-30M
-20M
-10M
0
-2400.0%
-2200.0%
-2000.0%
-1800.0%

Analyst Insights

View More

Analyst Price Targets

2.20
5.74 Average
2.4500 Current
8.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst Piper Sandler
Rating Action Reiterates
Rating Overweight
Price Action Raises
Price Target 6 -> 8

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    292.96M

  • Enterprise Value

    214.87M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    45.08

  • Price/Book (mrq)

    1.91

  • Enterprise Value/Revenue

    33.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -26.22%

  • Return on Equity (ttm)

    -60.75%

  • Revenue (ttm)

    6.49M

  • Net Income Avi to Common (ttm)

    -126M

  • Diluted EPS (ttm)

    -1.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    153.77M

  • Total Debt/Equity (mrq)

    49.32%

  • Levered Free Cash Flow (ttm)

    -48.66M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

2.4500 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 01/17/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/14/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/13/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/13/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: